X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs SHASUN PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD SHASUN PHARMA STRIDES SHASUN LTD/
SHASUN PHARMA
 
P/E (TTM) x 13.7 123.9 11.1% View Chart
P/BV x 1.6 8.5 18.6% View Chart
Dividend Yield % 0.6 0.2 267.1%  

Financials

 STRIDES SHASUN LTD   SHASUN PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
SHASUN PHARMA
Mar-14
STRIDES SHASUN LTD/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,27594 1,353.2%   
Low Rs91846 2,013.2%   
Sales per share (Unadj.) Rs389.6214.2 181.9%  
Earnings per share (Unadj.) Rs28.05.3 524.1%  
Cash flow per share (Unadj.) Rs48.915.8 309.1%  
Dividends per share (Unadj.) Rs4.501.00 450.0%  
Dividend yield (eoy) %0.41.4 28.7%  
Book value per share (Unadj.) Rs303.153.3 568.3%  
Shares outstanding (eoy) m89.4256.62 157.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.80.3 862.3%   
Avg P/E ratio x39.213.1 299.2%  
P/CF ratio (eoy) x22.44.4 507.4%  
Price / Book Value ratio x3.61.3 276.0%  
Dividend payout %16.118.7 85.9%   
Avg Mkt Cap Rs m98,0363,958 2,477.1%   
No. of employees `0005.8NA-   
Total wages/salary Rs m5,8812,164 271.8%   
Avg. sales/employee Rs Th6,005.9NM-  
Avg. wages/employee Rs Th1,014.0NM-  
Avg. net profit/employee Rs Th431.2NM-  
INCOME DATA
Net Sales Rs m34,83412,127 287.2%  
Other income Rs m1,686229 735.0%   
Total revenues Rs m36,52012,356 295.6%   
Gross profit Rs m6,4281,009 637.0%  
Depreciation Rs m1,872594 315.3%   
Interest Rs m2,269415 546.7%   
Profit before tax Rs m3,973230 1,729.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m40 -1,200.0%   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470-73 -646.3%   
Profit after tax Rs m2,501302 827.8%  
Gross profit margin %18.58.3 221.8%  
Effective tax rate %11.8-31.7 -37.4%   
Net profit margin %7.22.5 288.2%  
BALANCE SHEET DATA
Current assets Rs m38,1656,884 554.4%   
Current liabilities Rs m30,4028,456 359.5%   
Net working cap to sales %22.3-13.0 -172.0%  
Current ratio x1.30.8 154.2%  
Inventory Days Days7762 125.5%  
Debtors Days Days104108 97.1%  
Net fixed assets Rs m37,6394,970 757.3%   
Share capital Rs m894113 789.2%   
"Free" reserves Rs m26,2102,875 911.7%   
Net worth Rs m27,1053,020 897.4%   
Long term debt Rs m16,3771,817 901.1%   
Total assets Rs m81,16813,347 608.1%  
Interest coverage x2.81.6 177.1%   
Debt to equity ratio x0.60.6 100.4%  
Sales to assets ratio x0.40.9 47.2%   
Return on assets %5.95.4 109.4%  
Return on equity %9.210.0 92.2%  
Return on capital %12.113.3 90.5%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m13,4655,843 230.5%   
Fx outflow Rs m4,0762,173 187.6%   
Net fx Rs m9,3893,669 255.9%   
CASH FLOW
From Operations Rs m2,881398 724.7%  
From Investments Rs m-7,051-1,635 431.3%  
From Financial Activity Rs m3,3821,309 258.5%  
Net Cashflow Rs m-78871 -1,106.1%  

Share Holding

Indian Promoters % 27.7 39.2 70.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 3.6 1,050.0%  
FIIs % 8.6 17.6 48.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 39.6 65.4%  
Shareholders   56,241 20,750 271.0%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 16, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS